Patent ID: 9090940
Filing Date: 2015-07-28
Classification: A61P,C12Q,G01N,G16B

Abstract:
1. A method of diagnosing a cancer in a patient, which method comprises detecting and quantifying a marker in a biological sample isolated from the patient, wherein the marker is a tumor-associated antigen encoded by a nucleic acid that comprises the nucleic acid sequence of SEQ ID NO: 9, wherein the detecting comprises: (i) contacting the biological sample with an antibody (ii) detecting the formation of a complex between the antibody and the marker, and comparing the amount of the marker in the biological sample to the amount of the marker in a corresponding normal tissue; wherein the cancer is a cancer characterized by expression of the tumor-associated antigen selected from the group consisting of a gastric cancer, a breast cancer, an esophageal cancer, a pancreatic cancer, an ovary cancer, and a prostate cancer, wherein gene expression of the tumor-associated antigen in normal somatic cells is suppressed and wherein greater expression of the tumor-associated antigen in the biological sample as compared to corresponding normal tissue is indicative of the cancer.